Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects
Clinical trial NCT05948059 · COMPLETED
Trial details
- NCT number
- NCT05948059
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-11
- Primary completion
- 2024-05-10
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.